Featured Post

Latest Gold News

Some people will never get gold This billionaire quickly adding to gold position Ron Paul's prediction and what it could mean for ...

Thursday, April 28, 2011

Ratings on (NKTR) (NPSP) ( OTEX) (RNOW) (ROK) Reiterated

Ratings on Nektar Therapeutics (NASDAQ: NKTR), Nps Pharmaceuticals Incorporated (NASDAQ: NPSP), Open Text (NASDAQ: OTEX), RightNow Technologies (NASDAQ: RNOW) and Rockwell Automation Inc (NYSE: ROK) reiterated by analysts.

Deutsche Bank (NYSE:DB) reiterated a “buy” rating on Nektar Therapeutics (NKTR). They have a price target of $14 on the company.

Brean Murray reiterated a “buy” rating on Nps Pharmaceuticals Incorporated (NPSP).

Raymond James (NYSE:RJF) reiterated an “outperform” rating on Open Text (OTEX).

Morgan Stanley (NYSE:MS) reiterated an “equal weight” rating on shares of RightNow Technologies (RNOW).

JPMorgan Chase & Co. (NYSE:JPM) reiterated a “neutral” rating on shares of Rockwell Automation Inc (ROK).

No comments: